Consensus recommendation for meningococcal disease prevention for Hajj and Umra pilgrimage/ travel medicine;Recommandations consensuelles sur la prévention de la méningococcie pendant les pèlerinages (Hadj et Omra) et sur la médecine des voyages

Eastern Mediterranean Health Journal

Volumn 19, Issue 4, 2013, Pages 389-392

  Shibl, A ^a,b   Tufenkeji, H ^c   Khalil, M ^d   Memish, Z ^b,d  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b ALFAISAL UNIVERSITY   (Saudi Arabia)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^d MINISTRY OF HEALTH   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; CIPROFLOXACIN;

ARTICLE; CONSENSUS; DUBAI; HUMAN; INFECTION PREVENTION; MEDICAL EXPERT; MENINGOCOCCOSIS; MIDDLE EAST; NEISSERIA MENINGITIDIS; RELIGION; SAUDI ARABIA; TRAVEL; DISEASE TRANSMISSION; EMPORIATRICS; HEALTH CARE POLICY; MENINGITIS; VACCINATION;

EID: 84878060915     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2013.19.4.389     Document Type: Article

References (19)

1. Brigham KS, Sandora TJ. Neisseria meningitidis: epidemiology, treatment and prevention in adolescents. Current Opinion in Pediatrics, 2009, 21(4):437-443.
2. Al-Gahtani YM et al. Epidemiological investigation of an outbreak of meningococcal meningitis in Makkah (Mecca), Saudi Arabia, 1992. Epidemiology and Infection, 1995, 115(3):399-409.
3. Bilukha OO, Rosenstein N; National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and Reports, 2005, 54RR-7:1-21.
4. Trotter CL, Ramsay ME. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines. FEMS Microbiology Reviews, 2007, 31:101-107.
5. Khatami A, Pollard AJ. The epidemiology of meningococcal disease and the impact of vaccines. Expert Review of Vaccines, 2010, 9(3):285-298.
6. Khalil MK, Borrow R. Serogroup B meningococcal disease during Hajj: preparing for the worst scenario. Travel Medicine and Infectious Disease, 2009, 7(4):231-234
7. Von Gottberg A et al.; Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. Clinical Infectious Diseases, 2008, 46(3):377-386.
8. Infectious diseases report. Riyadh, Ministry of Health, 2008.
9. Harrison LH. Prospects for vaccine prevention of meningococcal infection. Clinical Microbiology Reviews, 2006, 19(1):142-164.
10. Findlow H et al. Meningococcal group C and w135 immunological hyporesponsiveness in african toddlers. Clinical and Vaccine Immunology, 2011, 18 (9):1492-1496.
11. Shibl A et al.; The Meningococcal Leadership Forum Expert Group. Consensus recommendation for meningococcal disease prevention in children and adolescents in the Middle East region. Journal of Epidemiology& Global Health, 2012, 2(1):23-30.
12. Girard MP et al. A review of vaccine research and development: meningococcal disease. Vaccine, 2006, 24(22):4692-4700.
13. Wilder-Smith A. Meningococcal vaccines: a neglected topic in travel medicine? Expert Review of Vaccines, 2009, 8(10):1343-1350.
14. International travel and health 2010. Geneva, World Health Organization, 2010, Chapter 6:117-119 (http://www.who.int/ith/en/, accessed 24 June, 2010).
15. Memish ZA, Venkatesh S, Ahmed QA. Travel epidemiology: the Saudi perspective. International Journal of Antimicrobial Agents, 2003, 21(2):96-101.
16. Lingappa JR et al. Serogroup W-135 meningococcal disease during the Hajj, 2000. Emerging Infectious Diseases, 2003, 9(6):665-671.
17. Hahné SJ et al. W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001. Lancet, 2002, 359(9306):582-583.
18. Mayer LW et al. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. Journal of Infectious Diseases, 2002, 185(11):1596-1605.
19. Stamboulian D et al. Safety and immunogenicity of an investigational quadrivalent meningococcal CRM (197) conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America. International Journal of Infectious Diseases, 2010, 14(10):e868-e875.